Skip to main content
Coloplast logo

Coloplast — Investor Relations & Filings

Ticker · COLO ISIN · DK0060448595 LEI · 529900NN7SOJ5QG82X67 CO Manufacturing
Filings indexed 2,485 across all filing types
Latest filing 2018-04-30 Transaction in Own Shar…
Country DK Denmark
Listing CO COLO

About Coloplast

https://www.coloplast.com

Coloplast is a company that develops, manufactures, and markets medical devices and services for people with intimate healthcare needs. Its principal business areas include Ostomy Care, Continence Care, Interventional Urology, and Wound & Skin Care. By collaborating closely with users, the company creates solutions designed to make life easier for individuals with personal and private medical conditions. Coloplast also provides comprehensive support programs and educational resources for both patients and healthcare professionals.

Recent filings

Filing Released Lang Actions
Share buy-back week 17/2018
Transaction in Own Shares Classification · 100% confidence The document is a corporate announcement regarding the company's share buyback program (Aktietilbagekøb). It details specific transactions made during week 17 of 2018, including the number of shares purchased, the price, and the total value, in accordance with 'Safe Harbour' regulations. This falls directly under the definition of a 'Transaction in Own Shares' (POS).
2018-04-30 Danish
Share buy-back week 17/2018
Transaction in Own Shares Classification · 100% confidence The document is a detailed report of transactions related to Coloplast's share buy-back programme for a specific week in April 2018. It includes transaction dates, number of shares repurchased, prices, and total amounts spent. The content focuses exclusively on share repurchase activity, with no financial statements, earnings data, or management commentary. It is not an announcement of a report but a detailed transactional disclosure. This matches the definition of a Transaction in Own Shares (POS) filing, which reports the company's buyback of its own shares.
2018-04-30 English
Share buy-back week 17/2018
Transaction in Own Shares Classification · 100% confidence The document is an announcement detailing specific transactions made by Coloplast in connection with its share buy-back programme. It lists the number of shares purchased, the buying price, and the total amount for the period of 23-26 April 2018. This aligns perfectly with the definition of 'Transaction in Own Shares' (POS), which covers reports of a company buying back its own shares.
2018-04-30 English
Transaction in Own Shares 2018
Transaction in Own Shares Classification · 100% confidence The document explicitly details 'Share buy-back week 16/2018' and provides a table showing the number of shares bought, the price, and the total amount transacted between April 16 and April 20, 2018, as part of an ongoing share buy-back program. This activity directly relates to the company purchasing its own shares. According to the definitions, 'Transaction in Own Shares (Code: POS)' covers 'Report of the company buying back or selling its own shares (share repurchase/issuance)'. Although it is a weekly update, the core subject matter is the transaction itself, making POS the most accurate classification over a general regulatory filing (RNS) or capital change (SHA).
2018-04-23 English
Transaction in Own Shares 2018
Transaction in Own Shares Classification · 99% confidence The document title explicitly mentions "Transaktionsdata i forbindelse med Coloplasts aktietilbagekøbsprogram, uge 16 23. april 2018" (Transaction data in connection with Coloplast's share buyback program, week 16 April 23, 2018). It details daily share purchases (BUY/B) made by the company during a specific period (April 16-20, 2018) and references EU regulations concerning share buyback programs. This activity directly corresponds to the definition of a company buying back or selling its own shares, which maps to the 'Transaction in Own Shares' category.
2018-04-23 English
Share buy-back week 16/2018
Transaction in Own Shares Classification · 100% confidence The document is a corporate announcement from Coloplast detailing specific transactions made under a share buyback program (aktietilbagekøbsprogram). It provides a table of daily share purchases, the total number of shares acquired, and the impact on the company's total share capital. This falls directly under the definition of 'Transaction in Own Shares' (POS).
2018-04-23 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.